Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
about
In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.Anything impossible with CRISPR/Cas9?Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy
P2860
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
@en
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
@nl
type
label
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
@en
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
@nl
prefLabel
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
@en
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
@nl
P2093
P2860
P1476
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11427-017-9033-0
P50
P577
2017-05-02T00:00:00Z